Phase 2 study of nivolumab in metastatic leiomyosarcoma of the uterus.

11007Background: Immune checkpoint inhibition (ICI) with monoclonal antibodies such as nivolumab has induced dramatic results in several types of cancers, although sarcoma subtypes have not been ex...